Latest news
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 20:05:00 GMTOcular Therapeutix (OCUL) Reports Q2 Loss, Beats Revenue Estimates - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:10:02 GMTOcular Therapeutix (NASDAQ:OCUL) Beats Expectations in Strong Q2 CY2026 - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 11:21:24 GMTOcular Therapeutix's Q2 Net Loss Widens, Revenue Flat - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 11:16:46 GMTOcular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 11:00:00 GMTPharmaceuticals Stocks Q1 In Review: Ocular Therapeutix (NASDAQ:OCUL) Vs Peers - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMTOutlook Therapeutics Targets Multibillion Dollar Ophthalmology Market With New Drug After FDA Rejection - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMT